Develop a nationally representative reference genome database to enable local research and innovation.
Improve citizen health outcomes by developing locally relevant precision medicine.
Improve drug regulation, costs, efficacy, and safety through pharmacogenomic data.
Create new revenue streams through pharmaceutical data licensing, collaborations, and tech transfer.
Create innovation ecosystems that connect healthcare providers, researchers, AI companies, and biotech partners to accelerate breakthroughs that benefit your population.
Strengthen health, data, and AI sovereignty by reducing the reliance on foreign solutions.
Create opportunities to expand into biobanking, proteomics, transcriptomics, and epigenomics to support future innovation.
We collaborate with governments to advise, design, and execute successful population genomics programs. Our expertise in genomics data, delivery, matched with our global relationships, enables us to help governments implement Population Genomics Programs that accomplish real results.
Across the world, nations including the US, the UK, Germany, the UAE, Singapore, and India are investing in Population Genomics Programs to transform healthcare and strengthen their biomedical future.
By establishing a National Genomics Program, governments can:
Our Offerings
Strategic Advisory
We partner with governments to build genomics programs that are visionary, viable, and sustainable. Our advisory team works with a cross-section of national leaders, both public and private, to develop end-to-end strategies that balance innovation, governance, cost, and impact to meet the unique needs of each nation’s program and people.
Strategy Development
Defining the vision, scope, and roadmap for implementing a sustainable National Genomics Program.
Stakeholder Alignment
Uniting policymakers, clinicians, researchers, and industry leaders around a shared mission and objectives.
Financing & Partnership Models
Designing pathways for public, private, or blended investment to underwrite the program.
Governance & Regulatory Frameworks
Establishing ethical, secure, and compliant program structures that protect patient privacy and national security while enabling research and development.
Infrastructure & Data Strategy
Ensuring usability, security, privacy, scalability, performance, maintainability, and other best practices in the use of technology and data required to achieve real program results.
We work with key stakeholders, both public and private, to create a practical implementation plan that enables governments to build genomic capacity, operate the program sustainably, and transfer required capabilities from partners to the country.
Program Design, Implementation, and Delivery
Governance
Vision, Goals, Objectives, Policies, Standards, Consent, Ethics, Compliance, Metrics, Outcomes
Infrastructure
Recruitment, Testing, Analytics, Informatics, Technology, Data
Capacity
Team, Resources, Capabilities
Sustainability
Clinical, Research, Commercial, Operational
Engagement
Patients, Public, Stakeholders, Team
Operations
People, Process, Finance, Risk Management
Knowledge Transfer
Education, Training
Led by our team of globally renowned domain experts, we collaborate with governments to design, finance, and deliver National Genomics Programs — from pilot to full-scale rollout — empowering nations to drive precision medicine, research, and equitable healthcare for generations to come.
Investment in genomics provides long-term returns including better health outcomes, healthcare cost savings, and job creation. A National Genomics Program is more than a health initiative — it’s a strategic investment to ensure a nation’s economic prosperity, the health of its citizens, and a basis for sustainable innovation.
Genomics Programs
